uniQure (QURE) Other Operating Expenses (2016 - 2026)
uniQure (QURE) posted quarterly Other Operating Expenses of $1.6 million for Q2 2026, down 38.47% year-over-year from $2.6 million in Q2 2025, and down 2.08% quarter-over-quarter from $1.6 million in Q1 2026.
uniQure (QURE) Other Operating Expenses (2016 - 2026) Analysis & Trends
uniQure's Other Operating Expenses history runs 8 years deep, the most recent figure standing at $1.6 million for Q2 2026.
- In Q2 2026, Other Operating Expenses fell 38.47% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $3.3 million (down 72.41% YoY), while the FY2025 annual figure was $628000.0, down 45.39% from the prior year.
- Other Operating Expenses for Q2 2026 stood at $1.6 million, down from $1.6 million in the prior quarter.
- The five-year high for Other Operating Expenses was $9.2 million in Q1 2024, with the low at -$21000.0 in Q4 2024.
- The 5-year median for Other Operating Expenses is $1.4 million (2023), against an average of $2.5 million.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses tumbled 100.24% in 2024, then soared 1654.73% in 2025.
- uniQure's Other Operating Expenses stood at $1.6 million in 2022, then soared by 435.45% to $8.8 million in 2023, then slumped by 100.24% to -$21000.0 in 2024, then jumped by 509.52% to $86000.0 in 2025, then jumped by 1758.14% to $1.6 million in 2026.
- Business Quant data shows QURE's Other Operating Expenses at $1.6 million in Q2 2026, $1.6 million in Q1 2026, and $86000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 8.31 Mn |
| Dec 31, 2024 | -21,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 148,000.00 |
| Mar 31, 2024 | 9.23 Mn |
| Dec 31, 2023 | 8.84 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 1.65 Mn |
| Sep 30, 2022 | 861,000.00 |
| Jun 30, 2022 | 832,000.00 |
| Dec 31, 2021 | 1.80 Mn |
| Jun 30, 2021 | 23.18 Mn |
| Sep 30, 2017 | 14.41 Mn |